IGF1 decreases with age [138], but remains an important neuroprotective agent as evidenced by clinical studies that, minus one exception [13], show elevated serum IGF1 levels correlating with improved functional outcomes in stroke patients [2, 70]. Here, IGF1 is linked to stroke disorder.